pharmaphorum

JANUARY 25, 2023

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.

Dosage 98

Dosage 98

pharmaphorum

JULY 13, 2022

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people worldwide, and their prevalence is only increasing, according to the World Health Organization. Utilising new digital technology, it turns out there are a number of ways to introduce objective measurement into the world of neurodegenerative diseases.

Dosage 98

Dosage Diabetes Drug Development 98

pharmaphorum

JANUARY 5, 2021

One bright spot in an otherwise dreadful year: the pharmaceutical industry has discovered it can do things it never dreamed possible. Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105